Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes

Simple item page
dc.contributor.authorIsmail, Heba M.
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2023-03-21T10:16:59Z
dc.date.available2023-03-21T10:16:59Z
dc.date.issued2021-10-21
dc.identifier.citationIsmail HM. Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes. J Clin Endocrinol Metab. 2021;106(11):e4786-e4788. doi:10.1210/clinem/dgab442en_US
dc.identifier.urihttps://hdl.handle.net/1805/31981
dc.language.isoen_USen_US
dc.publisherEndocrine Societyen_US
dc.relation.isversionof10.1210/clinem/dgab442en_US
dc.relation.journalThe Journal of Clinical Endocrinology & Metabolismen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePMCen_US
dc.subjectDDP-4 inhibitoren_US
dc.subjectAbnormal glucose toleranceen_US
dc.subjectCystic fibrosis-related diabetesen_US
dc.subjectGlucagonen_US
dc.subjectGlucagon-like peptide1 (GLP-1)en_US
dc.subjectGlucose-dependent insulinotropic polypeptideen_US
dc.subjectIncretinen_US
dc.subjectInsulinen_US
dc.subjectSitagliptinen_US
dc.titlePotential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetesen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes - PM.pdf
Size:
276.89 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Pediatrics Works